Stock Research: Vetoquinol

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Vetoquinol

ENXTPA:VETO FR0004186856
56
  • Value
    92
  • Growth
    15
  • Safety
    Safety
    78
  • Combined
    83
  • Sentiment
    35
  • 360° View
    360° View
    56
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Vetoquinol SA researches, develops, manufactures, markets, and sells veterinary drugs and products. The company operates in the animal health industry, with products for livestock and companion animals. It operates in Europe, North America, Africa, the Middle East, and Pacific Asia. In the last fiscal year, the company had 2501 employees, a market cap of $1097 million, profits of $346 million, and revenue of $558 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 56 (better than 56% compared with alternatives), overall professional sentiment and financial characteristics for the stock Vetoquinol are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Vetoquinol. The consolidated Value Rank has an attractive rank of 78, which means that the share price of Vetoquinol is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 78% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 92. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 35. Professional investors are more confident in 65% other stocks. The consolidated Growth Rank also has a low rank of 15, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 85 of its competitors have better growth. ...read more

more
Index
CAC All
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 79 61 56
Growth
15 12 51 85
Safety
Safety
92 96 88 62
Sentiment
35 23 84 42
360° View
360° View
56 46 96 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
27 19 41 65
Opinions Change
50 72 50 50
Pro Holdings
n/a 68 96 24
Market Pulse
40 22 67 51
Sentiment
35 23 84 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 79 61 56
Growth
15 12 51 85
Safety Safety
92 96 88 62
Combined
83 76 88 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
73 75 43 42
Price vs. Earnings (P/E)
65 69 65 64
Price vs. Book (P/B)
73 75 59 52
Dividend Yield
41 37 47 47
Value
78 79 61 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
22 28 35 39
Profit Growth
62 34 56 94
Capital Growth
22 12 40 44
Stock Returns
23 16 70 98
Growth
15 12 51 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
86 91 88 49
Refinancing
72 72 67 32
Liquidity
88 86 81 74
Safety Safety
92 96 88 62

Similar Stocks

Discover high‑ranked alternatives to Vetoquinol and broaden your portfolio horizons.

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Compagnie des Alpes

ENXTPA:CDA
Country: France
Industry: Leisure Facilities
Size: Medium
Full Stock Analysis

Synergie

ENXTPA:SDG
Country: France
Industry: HR- & Employment Services
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.